HCPCS code C9093 — Inj., susvimo, 0.1 mg. Status: Deleted. Effective Jul 1, 2022. Source: CMS HCPCS Level II.

C9093

Deleted

Inj., susvimo, 0.1 mg

Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

Code C9093 has been deleted from the HCPCS Level II set.

Termination date: Jun 30, 2022. Claims with a date of service on or after this day will be denied under this code.

No successor code has been identified. Consult the CMS HCPCS Update Summary for guidance.

Category: Outpatient PPS
Section: C-codes: Outpatient PPS
Effective: Jul 1, 2022
Terminated: Jun 30, 2022
Code type: alphanumeric

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q3
    Inj., susvimo, 0.1 mg
  • Deleted 2022-Q2
    Inj., susvimo, 0.1 mg